Honorary Professor

Rajiv Khanna

Email: 

Availability

Honorary Professor Rajiv Khanna is:
Available for supervision

Fields of research

Biological Sciences Immunology Medical microbiology

Qualifications

  • Bachelor of Science, Panjab University
  • Masters (Coursework) of Science, Panjab University
  • Doctor of Philosophy, Institution to be confirmed

Search Professor Rajiv Khanna’s works on UQ eSpace

84 works between 1998 and 2025
All (84) Journal Article (83) Conference Publication (1)

61 - 80 of 84 works

2003

Journal Article

Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions

Duraiswamy, Jaikumar, Burrows, Jacqueline M., Bharadwaj, Mandvi, Burrows, Scott R., Cooper, Leanne, Pimtanothai, Nattiya and Khanna, Rajiv (2003). Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. Journal of Virology, 77 (13), 7401-7410. doi: 10.1128/JVI.77.13.7401-7410.2003

Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions

2003

Journal Article

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy

Sherritt, M. A., Bharadwaj, M., Burrows, J. M., Morrison, L. E., Elliott, S. L., Davis, J. E., Kear, L. M., Slaughter, R. E., Bell, S. C., Galbraith, A. J., Khanna, R. and Moss, D. J. (2003). Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy. Transplantation, 75 (9), 1556-1560. doi: 10.1097/01.TP.0000058745.02123.6F

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy

2003

Journal Article

Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers

Elkington, Rebecca, Walker, Susan, Crough, Tania, Menzies, Moira, Tellam, Judy, Bharadwaj, Mandvi and Khanna, Rajiv (2003). Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. Journal of Virology, 77 (9), 5226-5240. doi: 10.1128/JVI.77.9.5226-5240.2003

Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers

2003

Journal Article

Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity

Tellam, J, Connolly, G, Webb, N, Duraiswamy, J and Khanna, R (2003). Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity. Blood, 102 (13), 4535-4540. doi: 10.1182/blood-2003-03-0870

Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity

2003

Journal Article

Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma

Duraiswamy, Jaikumar, Sherritt, Martina, Thomson, Scott, Tellam, Judy, Cooper, Leanne, Connolly, Geoff, Bharadwaj, Mandvi and Khanna, Rajiv (2003). Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma. Blood, 101 (8), 3150-3156. doi: 10.1182/blood-2002-10-3092

Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma

2003

Journal Article

Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertype

Burrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M. and Khanna, R. (2003). Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertype. Journal of Immunology, 171 (3), 1407-1412. doi: 10.4049/jimmunol.171.3.1407

Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertype

2002

Journal Article

RelB nuclear translocation mediated by C-terminal activator reigons of Epstein Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells

Pai, Saparna, O'Sullivan, Brendan J., Cooper, Leanne, Thomas, Ranjeny and Khanna, Rajiv (2002). RelB nuclear translocation mediated by C-terminal activator reigons of Epstein Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells. Journal of Virology, 76 (4), 1914-1921. doi: 10.1128/JVI.76.4.1914-1921.2002

RelB nuclear translocation mediated by C-terminal activator reigons of Epstein Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells

2002

Conference Publication

Will a vaccine to nasopharyngeal carcinoma retain orphan status?

Moss, D. J., Khanna, R. and Bharadwaj, M. (2002). Will a vaccine to nasopharyngeal carcinoma retain orphan status?. Orphan vaccines - Bridging the gap, Palm Cove, Queensland, 25-29 Aug, 2001. Basel: Karger.

Will a vaccine to nasopharyngeal carcinoma retain orphan status?

2002

Journal Article

Will a vaccine to nasopharyngeal carcinoma retain orphan status?

Moss, D. J., Khanna, R. and Bharadwaj, M. (2002). Will a vaccine to nasopharyngeal carcinoma retain orphan status?. Developments in Biologicals, 116, 252-256.

Will a vaccine to nasopharyngeal carcinoma retain orphan status?

2001

Journal Article

Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognition

Tellam, Judy, Sherritt, Martina, Thomson, Scott, Tellam, Ross, Moss, Denis J., Burrows, Scott R., Wiertz, Emmanuel and Khanna, Rajiv (2001). Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognition. Journal of Biological Chemistry, 276 (36), 33353-33360. doi: 10.1074/jbc.M104535200

Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognition

2001

Journal Article

Immunotherapeutic strategies for EBV-associated malignancies

Khanna, R., Tellam, J., Duraiswamy, J. and Cooper, L. (2001). Immunotherapeutic strategies for EBV-associated malignancies. Trends in Molecular Medicine, 76 (6), 270-276. doi: 10.1016/S1471-4914(01)02002-0

Immunotherapeutic strategies for EBV-associated malignancies

2001

Journal Article

Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design

Sherritt, M., Bharadwaj, M., Khanna, R. and Moss, D. J. (2001). Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design. Vaccine, 19 (27), 3769-3777. doi: 10.1016/S0264-410X(01)00085-8

Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design

1999

Journal Article

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999). Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 (18), 10391-10396. doi: 10.1073/pnas.96.18.10391

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease

1999

Journal Article

Cutting Edge: Silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: A novel implication of RNA processing for antigen presentation

Kienzle, Norbert, Sculley, Tom B., Greco, Sonia and Khanna, Rajiv (1999). Cutting Edge: Silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: A novel implication of RNA processing for antigen presentation. Journal of Immunology, 162 (12), 6963-6966.

Cutting Edge: Silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: A novel implication of RNA processing for antigen presentation

1999

Journal Article

Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCF-peptide interaction.

Khanna, Rajiv, Silins, Sharon L., Weng, Zhiping, Gatchell, David, Burrows, Scott R. and Cooper, Leanne (1999). Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCF-peptide interaction.. European Journal of Immunology, 29 (5), 1587-1597. doi: 10.1002/(SICI)1521-4141(199905)29:05

Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCF-peptide interaction.

1999

Journal Article

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease

Misko, Ihor S., Cross, Simone M., Khanna, Rajiv, Elliott, Suzanne L., Schmidt, Christopher, Pye, Stephanie J. and Silins, Sharon L. (1999). Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America, 96 (5), 2279-2284. doi: 10.1073/pnas.96.5.2279

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease

1999

Journal Article

EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine design

Khanna, Rajiv, Sherritt, Martina and Burrows, Scott R. (1999). EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine design. Journal of Immunology, 162 (5), 3063-3069. doi: 10.4049/jimmunol.162.5.3063

EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine design

1999

Journal Article

Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism

Burrows, Scott R., Khanna, Rajiv and Moss, Denis J. (1999). Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism. Blood, 93 (3), 1020-1024. doi: 10.1182/blood.v93.3.1020

Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism

1999

Journal Article

X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virus

Faulkner, Glenda C., Burrows, Scott R., Khanna, Rajiv, Moss, Denis J., Bird, A. Graham and Crawford, Dorothy H. (1999). X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virus. Journal of Virology, 73 (2), 1555-1564.

X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virus

1999

Journal Article

Immune control of EBV-associated diseases and its implication for vaccine design.

Khanna, R., Moss, D. J. and Burrows, S. R. (1999). Immune control of EBV-associated diseases and its implication for vaccine design.. Immunological Reviews, 70, 49-64.

Immune control of EBV-associated diseases and its implication for vaccine design.

Past funding

  • 2002
    Development of vaccination strategies against EBV-associated nasopharyngeal carcinoma using latent membrane protein 1 (LMP1)
    University of Queensland Research Development Grants Scheme
    Open grant

Availability

Honorary Professor Rajiv Khanna is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Breaking barriers: unlocking the potential of cytomegalovirus-specific T cells in allogeneic CAR T cell therapies

    Principal Advisor

    Other advisors: Honorary Professor Kum Kum Khanna

  • Doctor Philosophy

    Designing Therapeutic Strategies Targeting KRAS

    Principal Advisor

    Other advisors: Honorary Professor Kum Kum Khanna

  • Doctor Philosophy

    Adoptive T-cell therapy for HPV associated cancers

    Principal Advisor

  • Doctor Philosophy

    Investigating the differences between vaccine and infection induced T cell immunity to SARS-CoV-2

    Associate Advisor

    Other advisors: Professor Kirsty Short

  • Doctor Philosophy

    Combining spatial technology and gene expression signatures to characterize potent adoptive T cell immunotherapies

    Associate Advisor

Completed supervision

Enquiries

For media enquiries about Honorary Professor Rajiv Khanna's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au